- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Profitable Climbers
Danish Pharmaceuticals & Biotech Profitable Climbers
Results
2
0 new
2 companies
ChemoMetec
Market Cap: DKK 11.7b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 674.50
7D
-1.3%
1Y
34.5%
Genmab
Market Cap: DKK 123.6b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 2,007.00
7D
-5.5%
1Y
29.6%